Muhammad Rafehi

691 total citations
29 papers, 536 citations indexed

About

Muhammad Rafehi is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Muhammad Rafehi has authored 29 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Muhammad Rafehi's work include Adenosine and Purinergic Signaling (10 papers), Receptor Mechanisms and Signaling (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Muhammad Rafehi is often cited by papers focused on Adenosine and Purinergic Signaling (10 papers), Receptor Mechanisms and Signaling (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Muhammad Rafehi collaborates with scholars based in Germany, Poland and Oman. Muhammad Rafehi's co-authors include Christa E. Müller, Aliaa Abdelrahman, Sven Marcel Stefan, Jürgen Brockmöller, Ole Jensen, Vigneshwaran Namasivayam, Joachim C. Burbiel, Younis Baqi, Alexander Neumann and Mladen V. Tzvetkov and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Muhammad Rafehi

27 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Rafehi Germany 15 280 218 114 95 73 29 536
E.A. van Schaick Netherlands 13 246 0.9× 192 0.9× 96 0.8× 74 0.8× 37 0.5× 17 575
Erik T. Bodor United States 10 344 1.2× 57 0.3× 101 0.9× 50 0.5× 52 0.7× 16 688
Aliaa Abdelrahman Germany 21 442 1.6× 657 3.0× 108 0.9× 90 0.9× 246 3.4× 38 1.0k
Declan Flynn United States 8 310 1.1× 121 0.6× 42 0.4× 74 0.8× 45 0.6× 11 888
Meryem Köse Germany 16 349 1.2× 205 0.9× 136 1.2× 54 0.6× 210 2.9× 25 641
Duncan Armstrong United Kingdom 13 279 1.0× 45 0.2× 141 1.2× 31 0.3× 40 0.5× 20 744
Miriam Sindelar United States 15 724 2.6× 64 0.3× 40 0.4× 81 0.9× 45 0.6× 17 1.0k
Pedro Besada Spain 20 439 1.6× 404 1.9× 76 0.7× 28 0.3× 388 5.3× 50 964
Markus Muehlbacher Germany 7 445 1.6× 69 0.3× 30 0.3× 49 0.5× 48 0.7× 8 684
Nicola Giacchè Italy 13 283 1.0× 90 0.4× 23 0.2× 140 1.5× 142 1.9× 22 719

Countries citing papers authored by Muhammad Rafehi

Since Specialization
Citations

This map shows the geographic impact of Muhammad Rafehi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Rafehi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Rafehi more than expected).

Fields of papers citing papers by Muhammad Rafehi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Rafehi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Rafehi. The network helps show where Muhammad Rafehi may publish in the future.

Co-authorship network of co-authors of Muhammad Rafehi

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Rafehi. A scholar is included among the top collaborators of Muhammad Rafehi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Rafehi. Muhammad Rafehi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stefan, Sven Marcel, Sachin Puri, Muhammad Rafehi, et al.. (2025). Functional and structural polypharmacology of indazole-based privileged ligands to tackle the undruggability of membrane transporters. European Journal of Medicinal Chemistry. 287. 117234–117234. 2 indexed citations
2.
Stefan, Sven Marcel, Vigneshwaran Namasivayam, Gergely Gyimesi, et al.. (2025). Polypharmacology translates between species and phylogenetic distance: A functional, bioinformatic, and structural study on organic anion transporting polypeptides. Biochemical Pharmacology. 239. 117049–117049.
3.
Brockmöller, Jürgen, et al.. (2025). Transport of Small Aliphatic Amines by Polyspecific Solute Carriers: Deciphering Structure–Function Relationships. ACS Pharmacology & Translational Science. 8(8). 2777–2794.
4.
Stefan, Sven Marcel & Muhammad Rafehi. (2024). Medicinal polypharmacology—a scientific glossary of terminology and concepts. Frontiers in Pharmacology. 15. 1419110–1419110. 8 indexed citations
5.
Rafehi, Muhammad, et al.. (2024). Medicinal Polypharmacology in the Clinic – Translating the Polypharmacolome into Therapeutic Benefit. Pharmaceutical Research. 41(3). 411–417. 10 indexed citations
6.
Stefan, Sven Marcel & Muhammad Rafehi. (2023). Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development. Drug Development Research. 85(1). e22125–e22125. 15 indexed citations
7.
Stefan, Sven Marcel & Muhammad Rafehi. (2023). The big data challenge – and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and beyond. Neural Regeneration Research. 19(8). 1647–1648. 8 indexed citations
8.
Möhle, Luisa, Thomas Brüning, Muhammad Rafehi, et al.. (2022). A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development. International Journal of Molecular Sciences. 23(23). 14763–14763. 16 indexed citations
9.
Murugan, N. Arul, et al.. (2021). Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochemical Pharmacology. 197. 114871–114871. 13 indexed citations
10.
Matthaei, Johannes, Jürgen Brockmöller, Werner Steimer, et al.. (2021). Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients. Frontiers in Pharmacology. 12. 688950–688950. 17 indexed citations
11.
Voss, Jan, Muhammad Rafehi, Ramón Guixà-González, et al.. (2021). Unraveling binding mechanism and kinetics of macrocyclic Gαq protein inhibitors. Pharmacological Research. 173. 105880–105880. 12 indexed citations
12.
Jensen, Ole, et al.. (2021). Cellular Uptake of Psychostimulants – Are High- and Low-Affinity Organic Cation Transporters Drug Traffickers?. Frontiers in Pharmacology. 11. 609811–609811. 18 indexed citations
13.
Zinken, Sarah, Georgios Konstantinidis, Muhammad Rafehi, et al.. (2021). Thermal proteome profiling identifies the membrane-bound purinergic receptor P2X4 as a target of the autophagy inhibitor indophagolin. Cell chemical biology. 28(12). 1750–1757.e5. 30 indexed citations
14.
Neumann, Alexander, et al.. (2019). Ligand binding and activation of UTP-activated G protein-coupled P2Y2 and P2Y4 receptors elucidated by mutagenesis, pharmacological and computational studies. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(3). 129501–129501. 10 indexed citations
15.
Namasivayam, Vigneshwaran, Muhammad Rafehi, Jan Voss, et al.. (2019). Cell‐permeable high‐affinity tracers for Gq proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors. British Journal of Pharmacology. 177(8). 1898–1916. 20 indexed citations
16.
Rafehi, Muhammad, Frank Faltraco, Johannes Matthaei, et al.. (2019). Highly Variable Pharmacokinetics of Tyramine in Humans and Polymorphisms in OCT1, CYP2D6, and MAO-A. Frontiers in Pharmacology. 10. 1297–1297. 21 indexed citations
17.
Rafehi, Muhammad & Christa E. Müller. (2018). Tools and drugs for uracil nucleotide-activated P2Y receptors. Pharmacology & Therapeutics. 190. 24–80. 54 indexed citations
18.
Baqi, Younis, Thanigaimalai Pillaiyar, Aliaa Abdelrahman, et al.. (2018). 3-(2-Carboxyethyl)indole-2-carboxylic Acid Derivatives: Structural Requirements and Properties of Potent Agonists of the Orphan G Protein-Coupled Receptor GPR17. Journal of Medicinal Chemistry. 61(18). 8136–8154. 22 indexed citations
19.
Brunschweiger, Andreas, Pierre Koch, Muhammad Rafehi, et al.. (2016). 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5462–5480. 20 indexed citations
20.
Rafehi, Muhammad, et al.. (2016). Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925. Purinergic Signalling. 13(1). 89–103. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E.A. van Schaick Breakdown of academic impact, for papers by Erik T. Bodor Breakdown of academic impact, for papers by Aliaa Abdelrahman Breakdown of academic impact, for papers by Declan Flynn Breakdown of academic impact, for papers by Meryem Köse Breakdown of academic impact, for papers by Duncan Armstrong Breakdown of academic impact, for papers by Miriam Sindelar Breakdown of academic impact, for papers by Pedro Besada Breakdown of academic impact, for papers by Markus Muehlbacher Breakdown of academic impact, for papers by Nicola Giacchè
Rankless by CCL
2026